Jiangsu Hengrui Medicine Co., Ltd.
600276
Clasificación en acciones
#544
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Precio por acción
$6.89
Capitalización bursátil
$43.94B
Cambio (1 día)
-2.91%
Cambio (1 año)
-24.78%
País
CN
Comercio Jiangsu Hengrui Medicine Co., Ltd. (600276)
Categoría
Healthcare
EPS de Jiangsu Hengrui Medicine Co., Ltd. (600276)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Jiangsu Hengrui Medicine Co., Ltd., el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Jiangsu Hengrui Medicine Co., Ltd. desde 2001 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2025 | $0.17 | 24.16% |
| 2024 | $0.14 | 42.56% |
| 2023 | $0.10 | 8.71% |
| 2022 | $0.09 | -20.86% |
| 2021 | $0.11 | -27.04% |
| 2020 | $0.15 | 26.95% |
| 2019 | $0.12 | 29.68% |
| 2018 | $0.09 | 21.09% |
| 2017 | $0.08 | 29.95% |
| 2016 | $0.06 | 12.79% |
| 2015 | $0.05 | 35.40% |
| 2014 | $0.04 | 17.27% |
| 2013 | $0.03 | 20.88% |
| 2012 | $0.03 | 22.97% |
| 2011 | $0.02 | 21.98% |
| 2010 | $0.02 | 13.04% |
| 2009 | $0.02 | 62.63% |
| 2008 | $0.01 | 8.79% |
| 2007 | $0.01 | 116.67% |
| 2006 | 0.00 | 61.54% |
| 2005 | 0.00 | 36.84% |
| 2004 | 0.00 | 26.67% |
| 2003 | 0.00 | 25.00% |
| 2002 | 0.00 | -7.69% |
| 2001 | 0.00 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
